Compare ETFs: THNR

THNR

Comparison

SymbolCompany NameStock Price% ChangeAssetsExp. RatioPE RatioDiv. Yield
THNRAmplify Weight Loss Drug & Treatment ETF26.01-0.80%2.85M0.59%19.050.85%

Average Return

Top 25 Holdings

THNR - Amplify Weight Loss Drug & Treatment ETF
No.SymbolNameWeight
1 LLY Eli Lilly and Company 16.62%
2 NVO Novo Nordisk A/S 9.82%
3 REGN Regeneron Pharmaceuticals, Inc. 8.37%
4 AMGN Amgen Inc. 7.30%
5 TYO: 4519 Chugai Pharmaceutical Co., Ltd. 7.13%
6 MRK Merck & Co., Inc. 5.63%
7 SWX: ROG Roche Holding AG 5.21%
8 AZN AstraZeneca PLC 5.21%
9 ABBV AbbVie Inc. 4.77%
10 PFE Pfizer Inc. 4.69%
11 HKG: 1801 Innovent Biologics, Inc. 4.44%
12 TYO: 4507 Shionogi & Co., Ltd. 4.36%
13 HKG: 1093 CSPC Pharmaceutical Group Limited 3.50%
14 HIMS Hims & Hers Health, Inc. 3.25%
15 CPH: ZEAL Zealand Pharma A/S 3.19%
16 SRRK Scholar Rock Holding Corporation 1.92%
17 HKG: 1276 Jiangsu Hengrui Pharmaceuticals Co.,Ltd 1.40%
18 KRX: 128940 Hanmi Pharm. Co., Ltd. 1.16%
19 HKG: 3933 The United Laboratories International Holdings Limited 1.02%
20 AGPXX Short-Term Investment Trust - Invesco Government & Agency Portfolio 0.76%
21
n/a
OTHER ASSETS AND LIABILITIES 0.23%
22 n/a n/a n/a
23 n/a n/a n/a
24 n/a n/a n/a
25 n/a n/a n/a
View THNR holdings